Physician profile
Eri Hirofuji
NPI 1184099335
$2,077.04
in general payments reported to CMS, 2019-2025
17 companies · $560 in 2025
The $560 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.62 · 2022: $163 · 2023: $562 · 2024: $772 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.47 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $689.74 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Beigene USA, INC. | $301.11 | 2023-2024 | Brukinsa |
| Jazz Pharmaceuticals INC. | $254.52 | 2023-2024 | |
| Incyte Corporation | $137.56 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.40 | 2022 | |
| Astellas Pharma US INC | $99.99 | 2025 | |
| Rigel Pharmaceuticals, INC. | $94.02 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Celgene Corporation | $58.28 | 2023-2025 | Reblozyl |
| Astrazeneca Pharmaceuticals LP | $57.07 | 2025 | Calquence |
| Sobi, INC | $46.46 | 2024-2025 | |
| Daiichi Sankyo INC. | $45.58 | 2024 | Vanflyta |
| Seagen INC. | $37.52 | 2023 | Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $31.95 | 2024 | Livtencity |
| Glaxosmithkline, LLC. | $28.97 | 2025 | Blenrep |
| Geron Corporation | $27.09 | 2025 | Rytelo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.16 | 2024 | |
| Amgen INC. | $20.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eri Hirofuji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.